Health Catalyst (HCAT) Stock Price, News & Analysis

Company Overview

Health Catalyst (NASDAQ: HCAT) is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information.

The core of Health Catalyst’s offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment. Built on cloud-native architecture, DOS provides analytics applications and tools for care management, performance improvement, population health and financial analysis.

In addition to its platform technology, Health Catalyst provides professional services including implementation support, data engineering, performance improvement consulting and change management. These services are designed to help health systems and hospitals accelerate adoption of data-driven practices, improve clinical quality and reduce costs through evidence-based interventions.

Health Catalyst serves more than 450 healthcare organizations across the United States and has expanded its footprint into select international markets. The company is led by an executive team with deep experience in health IT and population health, and it partners with clients ranging from community hospitals to large integrated health systems to drive measurable improvements in patient outcomes and operational efficiency.

Key Stats

• Today's Range: $2.87 to $3.16
• 50-Day Range: $2.70 to $4.09
• 52-Week Range: $2.52 to $9.24
• Volume: 542,186 shs
• Average Volume: 727,091 shs
• Market Capitalization: $212.17 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $4.73
• Consensus Rating: Hold

Health Catalyst Stock Analysis - MarketRank™

Health Catalyst scored higher than 86% of companies evaluated by MarketBeat, and ranked 162nd out of 954 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.1 / 5
• Analyst Rating: Hold

Consensus Rating

Health Catalyst has received a consensus rating of Hold. The company's average rating score is 2.27, and is based on 3 buy ratings, 8 hold ratings, and no sell ratings.

Upside Potential

Health Catalyst has a consensus price target of $4.73, representing about 60.5% upside from its current price of $2.95.

Amount of Analyst Coverage

Health Catalyst has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Health Catalyst are expected to grow in the coming year, from ($0.33) to ($0.29) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Health Catalyst is -1.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Health Catalyst is -1.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Health Catalyst has a P/B Ratio of 0.49. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

7.66% of the float of Health Catalyst has been sold short.

Short Interest Ratio / Days to Cover

Health Catalyst has a short interest ratio ("days to cover") of 7.1.

Change versus previous month

Short interest in Health Catalyst has recently increased by 7.14%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Health Catalyst does not currently pay a dividend.

Dividend Growth

Health Catalyst does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 3.8 / 5
• Environmental Score: -0.91

Percentage of Shares Shorted

7.66% of the float of Health Catalyst has been sold short.

Short Interest Ratio / Days to Cover

Health Catalyst has a short interest ratio ("days to cover") of 7.1.

Change versus previous month

Short interest in Health Catalyst has recently increased by 7.14%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 0.93

News Sentiment

Health Catalyst has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 12 news articles for Health Catalyst this week, compared to 5 articles on an average week.

Search Interest

1 people have searched for HCAT on MarketBeat in the last 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Health Catalyst insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $20,686.00 in company stock.

Percentage Held by Insiders

Only 2.60% of the stock of Health Catalyst is held by insiders.

Percentage Held by Institutions

85.00% of the stock of Health Catalyst is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

HCAT Stock Analysis - Frequently Asked Questions

How have HCAT shares performed this year?

Health Catalyst's stock was trading at $7.07 at the start of the year. Since then, HCAT stock has decreased by 58.3% and is now trading at $2.9450.

How were Health Catalyst's earnings last quarter?

Health Catalyst, Inc. (NASDAQ:HCAT) posted its quarterly earnings data on Wednesday, November, 6th. The company reported $0.07 EPS for the quarter, missing the consensus estimate of $0.10 by $0.03. The firm's revenue for the quarter was up 3.5% compared to the same quarter last year.
Read the conference call transcript.

When did Health Catalyst IPO?

Health Catalyst (HCAT) raised $129 million in an initial public offering on Thursday, July 25th 2019. The company issued 6,000,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and William Blair served as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers.

Who are Health Catalyst's major shareholders?

Health Catalyst's top institutional shareholders include First Light Asset Management LLC (17.38%), Primecap Management Co. CA (2.85%), Geode Capital Management LLC (2.39%) and Acadian Asset Management LLC (1.67%). Insiders that own company stock include Daniel D Burton, Bryan Truman Hunt, Kevin Lee Freeman, Daniel Lesueur, Benjamin Landry, Jason Alger, Linda Llewelyn and Duncan Gallagher.
View institutional ownership trends.

How do I buy shares of Health Catalyst?

Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Health Catalyst own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Health Catalyst investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), AU Optronics (AUOTY), Voyager Therapeutics (VYGR) and DiamondRock Hospitality (DRH).

Company Calendar

• Last Earnings: 11/06/2024
• Today: 9/15/2025
• Next Earnings (Estimated): 11/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MEDICAL INFO SYS
• Sub-Industry: Computer Software
• Current Symbol: NASDAQ:HCAT
• CIK: 1636422
• Web: www.healthcatalyst.com
• Phone: (801) 708-6800
• Fax: N/A
• Employees: 1,500
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Health Catalyst: $4.73
• High Price Target: $6.00
• Low Price Target: $3.50
• Potential Upside/Downside: +55.2%
• Consensus Rating: Hold
• Rating Score (0-4): 2.27
• Research Coverage: 11 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.51)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$69.50 million
• Net Margins: -31.67%
• Pretax Margin: -31.53%
• Return on Equity: -7.21%
• Return on Assets: -3.28%

Debt

• Debt-to-Equity Ratio: 0.44
• Current Ratio: 1.83
• Quick Ratio: 1.83

Sales & Book Value

• Annual Sales: $306.58 million
• Price / Sales: 0.70
• Cash Flow: $0.34 per share
• Price / Cash Flow: 8.88
• Book Value: $6.00 per share
• Price / Book: 0.51

Miscellaneous

• Outstanding Shares: 70,370,000
• Free Float: 68,544,000
• Market Cap: $214.28 million
• Optionable: Optionable
• Beta: 1.53